Celon Pharma S.A. (WSE: CLN)
Poland
· Delayed Price · Currency is PLN 27.45
+1.05 (3.98%)
Nov 20, 2024, 5:04 PM CET
Celon Pharma Ratios and Metrics
Market cap in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 1,400 | 789 | 716 | 1,691 | 1,825 | 1,787 | Upgrade
|
| Market Cap Growth | 0.90% | 10.32% | -57.68% | -7.35% | 2.14% | 27.04% | Upgrade
|
| Enterprise Value | 1,294 | 704 | 578 | 1,487 | 1,807 | 1,710 | Upgrade
|
| Last Close Price | 26.00 | 15.38 | 13.87 | 32.20 | 39.31 | 38.39 | Upgrade
|
| PE Ratio | - | - | - | - | - | 149.69 | Upgrade
|
| Forward PE | - | - | - | - | 51.01 | - | Upgrade
|
| PS Ratio | 6.42 | 3.69 | 3.69 | 8.62 | 11.59 | 17.47 | Upgrade
|
| PB Ratio | 2.89 | 1.77 | 1.49 | 3.05 | 5.30 | 4.01 | Upgrade
|
| P/TBV Ratio | 1.78 | 1.83 | 1.56 | 3.21 | 5.96 | 4.03 | Upgrade
|
| P/FCF Ratio | - | - | - | 650.25 | - | - | Upgrade
|
| P/OCF Ratio | 141.01 | - | - | 38.47 | 25.44 | - | Upgrade
|
| EV/Sales Ratio | 6.26 | 3.29 | 2.98 | 7.58 | 11.48 | 16.73 | Upgrade
|
| EV/EBITDA Ratio | - | 81.54 | - | 53.42 | 70.90 | 63.72 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | - | 275.05 | Upgrade
|
| EV/FCF Ratio | -112.46 | - | - | 572.04 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.06 | 0.06 | 0.03 | 0.07 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | - | 1.24 | 5.92 | 0.52 | 1.00 | 0.06 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 5.74 | - | - | Upgrade
|
| Asset Turnover | 0.35 | 0.35 | 0.29 | 0.32 | 0.28 | 0.18 | Upgrade
|
| Inventory Turnover | 2.21 | 2.06 | 2.15 | 2.32 | 1.23 | 1.42 | Upgrade
|
| Quick Ratio | 2.23 | 1.89 | 1.70 | 2.95 | 0.75 | 4.33 | Upgrade
|
| Current Ratio | 2.61 | 2.20 | 2.04 | 3.23 | 1.04 | 5.53 | Upgrade
|
| Return on Equity (ROE) | -9.82% | -6.08% | -7.60% | -2.58% | -0.23% | 2.67% | Upgrade
|
| Return on Assets (ROA) | -4.75% | -2.92% | -3.51% | -1.07% | -0.46% | 0.67% | Upgrade
|
| Return on Capital (ROIC) | -5.77% | -3.63% | -4.40% | -1.41% | -0.63% | 0.87% | Upgrade
|
| Earnings Yield | -3.43% | -3.56% | -5.49% | -0.69% | -0.05% | 0.67% | Upgrade
|
| FCF Yield | -0.82% | -5.21% | -5.40% | 0.15% | -1.52% | -3.92% | Upgrade
|
| Dividend Yield | 0.29% | 0.52% | 0.65% | 0.90% | 0.18% | 0.21% | Upgrade
|
| Payout Ratio | 0.00% | - | - | - | - | 60.33% | Upgrade
|
| Buyback Yield / Dilution | -0.04% | -0.04% | -9.32% | -3.74% | - | - | Upgrade
|
| Total Shareholder Return | 0.25% | 0.48% | -8.67% | -2.84% | 0.18% | 0.21% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.